OpenBench and HemoShear Therapeutics Agree to Pursue Rare Disease Target Using Artificial Intelligence

/PRNewswire/ -- OpenBench, Inc., an emerging leader in AI-enabled small molecule discovery, entered into an agreement with HemoShear Therapeutics, Inc., a...

Related Keywords

James Yoder ,Openbench Inc ,Hemoshear Therapeutics Inc ,Prnewswire Openbench Inc , ,Hemoshear Therapeutics ,Openbench ,Health Care Amp Hospitals ,Computer Amp Electronics ,Biotechnology ,Medical Pharmaceuticals ,Artificial Intelligence ,Licensing ,